These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22263340)

  • 1. [Chronic hepatitis C: current therapy and perspectives].
    Ladero Quesada JM
    An R Acad Nac Med (Madr); 2010; 127(3):413-24; discussion 424-31. PubMed ID: 22263340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Hunyady B; Kovács B; Battyáni Z
    Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hepatitis C infection: towards eradication of chronic virus].
    Ahola T; Kaukinen P
    Duodecim; 2012; 128(18):1911-7. PubMed ID: 23088003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C.
    Bihl F; Negro F
    Minerva Med; 2009 Dec; 100(6):459-65. PubMed ID: 20010481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
    Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New class of medicines for chronic hepatitis C].
    Aronson SJ; de Bruijne J; Schinkel J; Weegink CJ; van der Valk M; Reesink HW
    Ned Tijdschr Geneeskd; 2012; 156(10):A3840. PubMed ID: 22394440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future management of chronic hepatitis C infection.
    Cross TJ; Antoniades CG; Harrison PM
    Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapies for hepatitis C virus infection.
    Soriano V; Peters MG; Zeuzem S
    Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future perspectives: towards interferon-free regimens for HCV.
    Gane E
    Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Future prospects for hepatitis C treatment: without interferon and ribavirin?].
    Lens S; Alfaro I
    Gastroenterol Hepatol; 2014 May; 37(5):311-21. PubMed ID: 24679376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis viral C: new associations].
    Ouzan D
    Presse Med; 2013 Jun; 42(6 Pt 1):977-82. PubMed ID: 23021659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Boceprevir: new possibilities for antiviral treatment of chronic hepatitis C].
    Nikitin IG; Baĭkova IE; Gogova LM; Volynkina VM; Kisliakov VA
    Ter Arkh; 2013; 85(2):76-84. PubMed ID: 23653945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs for hepatitis C virus.
    Pockros PJ
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
    Pol S; Corouge M; Mallet V; Sogni P
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCV entry as a new therapeutic target in chronic hepatitis C].
    Dabrowska MM; Panasiuk A; Flisiak R
    Pol Merkur Lekarski; 2009 Aug; 27(158):140-3. PubMed ID: 19856882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-based therapy for chronic hepatitis C: current and future perspectives.
    Zeuzem S
    Nat Clin Pract Gastroenterol Hepatol; 2008 Nov; 5(11):610-22. PubMed ID: 18838975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.